FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Diagn Invest / Tetanus in animals.
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc2020; 32(2); 184-191; doi: 10.1177/1040638720906814

Tetanus in animals.

Abstract: Tetanus is a neurologic disease of humans and animals characterized by spastic paralysis. Tetanus is caused by tetanus toxin (TeNT) produced by Clostridium tetani, an environmental soilborne, gram-positive, sporulating bacterium. The disease most often results from wound contamination by soil containing C. tetani spores. Horses, sheep, and humans are highly sensitive to TeNT, whereas cattle, dogs, and cats are more resistant. The diagnosis of tetanus is mainly based on the characteristic clinical signs. Identification of C. tetani at the wound site is often difficult.
Get Full Text
Publication Date: 2020-02-18 PubMed ID: 32070229PubMed Central: PMC7081504DOI: 10.1177/1040638720906814Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study presents an overview of Tetanus: a neurological disease affecting humans and animals, caused by the toxin produced by the bacterium Clostridium tetanii, which mostly infects via contaminated wounds. The paper provides detail on varying susceptibility of species to the toxin and the difficulties in diagnosing the disease.

Overview of Tetanus

  • Tetanus is defined as a neurological disease that impacts both humans and animals and is characterized by spastic paralysis, a condition where the muscles constantly contract causing stiffness or tightness which can interfere with normal movement.
  • The cause of Tetanus is a toxin named TeNT (Tetanus toxin) produced by the bacterium Clostridium tetani. This bacteria is soilborne, gram-positive and can produce spores.

Transmission of Tetanus

  • The disease generally occurs from a contamination of wounds with the soil that houses these bacterial spores.
  • Once the spores make entry into a host body through an open wound, they turn into bacteria that produce the toxin causing the disease.

Sensitivity of Species to Tetanus

  • Horses, sheep, and humans are noted to be highly vulnerable to TeNT. These species exhibit a high sensitivity towards the bacteria, and can get severely affected by it.
  • On the other hand, cattle, dogs, and cats show more resistance to this toxin, illustrating that the effects of tetanus can significantly vary depending on the species.

Diagnosis of Tetanus

  • The diagnosis of Tetanus primarily depends on the identification of distinct clinical signs related to the disease.
  • However, the process is often complicated as pinpointing the presence of Clostridium tetani at the wound site can be challenging, making the diagnosis difficult.

Cite This Article

APA
Popoff MR. (2020). Tetanus in animals. J Vet Diagn Invest, 32(2), 184-191. https://doi.org/10.1177/1040638720906814

Publication

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 32
Issue: 2
Pages: 184-191

Researcher Affiliations

Popoff, Michel R
  • Bacterial Toxins, Institut Pasteur, Paris, Cedex, France.

MeSH Terms

  • Animals
  • Animals, Domestic
  • Clostridium tetani / physiology
  • Mammals
  • Tetanus / diagnosis
  • Tetanus / microbiology
  • Tetanus / veterinary

Conflict of Interest Statement

Declaration of conflicting interests: The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 58 references
  1. Acke E. Tetanus in the dog: review and a case-report of concurrent tetanus with hiatal hernia. Ir Vet J 2004;57:593–597.
    pmc: PMC3113811pubmed: 21851651
  2. Akbulut D. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill 2005;10:172–174.
    pubmed: 16280612
  3. Anderson JF. The influence of concentration (Gibson’s method) on the presence of tetanus toxin in blood serum. J Exp Med 1909;11:656–658.
    pmc: PMC2124735pubmed: 19867275
  4. Aslani MR. Outbreak of tetanus in lambs. Vet Rec 1998;142:518–519.
    pubmed: 9618879
  5. Bandt C. Retrospective study of tetanus in 20 dogs: 1988–2004. J Am Anim Hosp Assoc 2007;43:143–148.
    pubmed: 17473020
  6. Bercsenyi K. Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus. Science 2014;346:1118–1123.
    pubmed: 25430769
  7. Bleck TP. Tetanus: pathophysiology, management, and prophylaxis. Dis Mon 1991;37:545–603.
    pubmed: 1874121
  8. Bohnert S. Uptake and transport of clostridium neurotoxins. In: Alouf JE, Popoff MR, eds. The Comprehensive Sourcebook of Bacterial Protein Toxins. 3rd ed. Amsterdam: Elsevier Academic, 2006:390–408.
  9. Bohnert S, Schiavo G. Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J Biol Chem 2005;280:42336–42344.
    pubmed: 16236708
  10. Burkitt JM. Risk factors associated with outcome in dogs with tetanus: 38 cases (1987–2005). J Am Vet Med Assoc 2007;230:76–83.
    pubmed: 17199496
  11. Bytchenko B. Microbiology of tetanus. In: Veronesi R, ed. Tetanus: Important New Concepts. Amsterdam: Excerpta Medica, 1981:28–39.
  12. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, et al., eds. 13th ed. Washington, DC: Public Health Foundation, 2015.
  13. Chen C. Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem 2009;284:26569–26577.
    pmc: PMC2785345pubmed: 19602728
  14. Coetzee JF. A survey of castration methods and associated livestock management practices performed by bovine veterinarians in the United States. BMC Vet Res 2010;6:12.
    pmc: PMC2841153pubmed: 20199669
  15. Deinhardt K. Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol 2006;174:459–471.
    pmc: PMC2064241pubmed: 16880274
  16. Deinhardt K. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 2006;52:293–305.
    pubmed: 17046692
  17. Delbrassinne L, Vanderpas J. The mouse toxicity bioassay as a laboratory confirmation test for tetanus. Acta Clin Belg 2015;70:77–78.
    pubmed: 25224543
  18. De Risio L. Focal canine tetanus: diagnostic value of electromyography. J Small Anim Pract 2006;47:278–280.
    pubmed: 16674723
  19. Driemeier D. Outbreaks of tetanus in beef cattle and sheep in Brazil associated with disophenol injection. J Vet Med A Physiol Pathol Clin Med 2007;54:333–335.
    pubmed: 17650154
  20. Ebisawa I. Density and distribution of Clostridium tetani in the soil. Jpn J Exp Med 1986;56:69–74.
    pubmed: 3525907
  21. Ergonul O. An unexpected tetanus case. Lancet Infect Dis 2016;16:746–752.
    pubmed: 27301930
  22. Fischer A, Montal M. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem 2007;282:29604–29611.
    pubmed: 17666397
  23. Fischer A. Botulinum neurotoxin devoid of receptor binding domain translocates active protease. PLoS Pathog 2008;4:e1000245.
    pmc: PMC2596314pubmed: 19096517
  24. Galloux M. Membrane interaction of botulinum neurotoxin A translocation (T) domain. The belt region is a regulatory loop for membrane interaction. J Biol Chem 2008;283:27668–27676.
    pubmed: 18693250
  25. Ganesh M. Detection of Clostridium tetani in human clinical samples using tetX specific primers targeting the neurotoxin. J Infect Public Health 2016;9:105–109.
    pubmed: 26220795
  26. Hachisuka Y. The effect of oxidation-reduction potential on spore germination, outgrowth, and vegetative growth of Clostridium tetani, Clostridium butyricum, and Bacillus subtilis. Microbiol Immunol 1982;26:803–811.
    pubmed: 6818433
  27. Haneda J. [Distribution of Clostridium tetani in topsoil from Sagamihara, central Japan]. Kansenshogaku Zasshi 2006;80:690–693.
    pubmed: 17176856
  28. Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel) 2013;5:73–83.
    pmc: PMC3564069pubmed: 23299659
  29. Huang SW. The utilization of a commercial soil nucleic acid extraction kit and PCR for the detection of Clostridium tetanus and Clostridium chauvoei on farms after flooding in Taiwan. J Vet Med Sci 2013;75:489–495.
    pubmed: 23208321
  30. Jiang D. Rapid, sensitive, and specific detection of Clostridium tetani by loop-mediated isothermal amplification assay. J Microbiol Biotechnol 2013;23:1–6.
    pubmed: 23314360
  31. Kegel B. An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product. Toxicol In Vitro 2007;21:1641–1649.
    pubmed: 17826026
  32. Keyel PA. Macrophage responses to bacterial toxins: a balance between activation and suppression. Immunol Res 2011;50:118–123.
    pmc: PMC5436281pubmed: 21717083
  33. Kiessig ST. A solid-phase enzyme immunoassay for the detection of tetanus toxin using human and murine monoclonal antibodies. J Basic Microbiol 1991;31:135–140.
    pubmed: 1880715
  34. Kobayashi T. [Distribution of Clostridium botulinum and Clostridium tetani in Okinawa Prefecture]. Kansenshogaku Zasshi 1992;66:1639–1644.
    pubmed: 1294669
  35. Koriazova LK, Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 2003;10:13–18.
    pubmed: 12459720
  36. Lalli G. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 2003;11:431–437.
    pubmed: 13678859
  37. Lalli G, Schiavo G. Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neutrophin receptor p75NTR. J Cell Biol 2002;156:233–239.
    pmc: PMC2199221pubmed: 11807088
  38. Lotfollahzadeh S. Tetanus outbreak in a sheep flock due to ear tagging. Vet Med Sci 2018:139.
    pmc: PMC6498517pubmed: 30549234
  39. Masuyer G. The structure of the tetanus toxin reveals pH-mediated domain dynamics. EMBO Rep 2017;18:1306–1317.
    pmc: PMC5538627pubmed: 28645943
  40. Meunier FA. Molecular mechanism of action of botulinal neurotoxins and the synaptic remodeling they induce in vivo at the skeletal neuromuscular junction. In: Massaro J, ed. Handbook of Neurotoxicology. Vol. 1 Totowa, NJ: Humana Press, 2002:305–347.
  41. Nagoba B. Molecular methods for identification of Clostridium tetani by targeting neurotoxin. Methods Mol Biol 2017;1600:37–47.
    pubmed: 28478555
  42. Plourde-Owobi L. Molecular characterization of Clostridium tetani strains by pulsed-field gel electrophoresis and colony PCR. Appl Environ Microbiol 2005;71:5604–5606.
    pmc: PMC1214643pubmed: 16151158
  43. Popoff MR. Detection of toxigenic clostridia. In: Sachse K, Frey J, eds. PCR Detection of Microbial Pathogens. 1st ed. (Methods in Molecular Biology, Vol. 216) Totowa, NJ: Humana Press, 2002:137–152.
    pubmed: 12512361
  44. Poulain B. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action?. Botulinum J 2008;1:14–87.
  45. Poulain B. Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. In: Alouf JE, Popoff MR, eds. The Sourcebook of Bacterial Protein Toxins. 3rd ed. Amsterdam: Elsevier Academic, 2006:348–389.
  46. Rethy L, Rethy LA. Human lethal dose of tetanus toxin. Lancet 1997;350:1518.
    pubmed: 9388402
  47. Rossetto O. Tetanus neurotoxin. Toxicon 2013;66:59–63.
    pubmed: 23419592
  48. Rummel A. Two carbohydrate binding sites in the Hcc-domain of tetanus neurotoxin are required for toxicity. J Mol Biol 2003;326:835–847.
    pubmed: 12581644
  49. Sathish S, Swaminathan K. Genetic diversity among toxigenic clostridia isolated from soil, water, meat and associated polluted sites in South India. Indian J Med Microbiol 2009;27:311–320.
    pubmed: 19736399
  50. Schiavo G. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000;80:717–766.
    pubmed: 10747206
  51. Shea A. Association between clinically probable REM sleep behavior disorder and tetanus in dogs. J Vet Intern Med 2018;32:2029–2036.
    pmc: PMC6272037pubmed: 30315605
  52. Smith LDS. Clostridium tetani. In: The Pathogenic Anaerobic Bacteria. 2nd ed. (American Lecture Series no. 980.) Springfield IL: Charles C. Thomas, 1975:177–201.
  53. Smith LDS, Williams BL. The Pathogenic Anaerobic Bacteria. 3rd ed. (American Lecture Series no. 1064.) Springfield, IL: Charles C. Thomas, 1984.
  54. Sprott KR. Generalized tetanus in a Labrador retriever. Can Vet J 2008;49:1221–1223.
    pmc: PMC2583421pubmed: 19252716
  55. Takeda M. Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis 2005;49:376–381.
    pubmed: 16252491
  56. van Galen G. Retrospective evaluation of 155 adult equids and 21 foals with tetanus from Western, Northern, and Central Europe (2000–2014). Part 2: Prognostic assessment. J Vet Emerg Crit Care (San Antonio) 2017;27:697–706.
    pubmed: 28960891
  57. Wilkins CA. Occurrence of Clostridium tetani in soil and horses. S Afr Med J 1988;73:718–720.
    pubmed: 3289126
  58. Wright GP. The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacol Rev 1955;7:413–465.
    pubmed: 13289310
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.